These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9448969)

  • 1. Sex steroids and malignancies.
    Baum M
    Clin Oncol (R Coll Radiol); 1997; 9(6):395-9. PubMed ID: 9448969
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex steroids and malignancies.
    Baum M
    Osteoporos Int; 1997; 7 Suppl 1():S18-22. PubMed ID: 9205641
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
    Rebbeck TR; Troxel AB; Shatalova EG; Blanchard R; Norman S; Bunin G; Demichele A; Schinnar R; Berlin JA; Strom BL
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1318-20. PubMed ID: 17548708
    [No Abstract]   [Full Text] [Related]  

  • 4. The estrogen paradox.
    Santen RJ; Allred DC
    Nat Clin Pract Endocrinol Metab; 2007 Jul; 3(7):496-7. PubMed ID: 17519914
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormonal and genetic risk factors for breast cancer.
    Clamp A; Danson S; Clemons M
    Surgeon; 2003 Feb; 1(1):23-31. PubMed ID: 15568421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.
    Chlebowski RT; Prentice RL
    J Natl Cancer Inst; 2008 Oct; 100(19):1341-3. PubMed ID: 18812547
    [No Abstract]   [Full Text] [Related]  

  • 7. Estrogen and the risk of breast cancer.
    Clemons M; Goss P
    N Engl J Med; 2001 Jan; 344(4):276-85. PubMed ID: 11172156
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone replacement and the risk of breast cancer in Turner's syndrome.
    Bösze P; Tóth A; Török M
    N Engl J Med; 2006 Dec; 355(24):2599-600. PubMed ID: 17167149
    [No Abstract]   [Full Text] [Related]  

  • 9. Women at high risk for breast cancer.
    Gross RE
    Am J Nurs; 1998 Apr; 98(4):55-8. PubMed ID: 9556686
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 11. Estrogen replacement therapy and breast cancer.
    Maguire PJ
    J Reprod Med; 1993 Mar; 38(3):183-5. PubMed ID: 8487233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and cancer.
    Creasman WT
    Gynecol Oncol; 2002 Jul; 86(1):1-9. PubMed ID: 12079291
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and breast cancer: an overview.
    Theriault RL
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():87-90; discussion 90-1. PubMed ID: 8624349
    [No Abstract]   [Full Text] [Related]  

  • 15. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 16. [Are estrogens carcinogens?].
    Emons G; Gründker C; Hanf V
    Zentralbl Gynakol; 2002 Dec; 124(12):559-65. PubMed ID: 12822069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The breast cancer risk in postmenopausal estrogen substitution. The dilemma of risk assessment].
    Lippert TH; Mück AO
    Dtsch Med Wochenschr; 1997 Jul; 122(28-29):908-11. PubMed ID: 9264923
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Archer DF; Bush T; Nachtigall LE
    J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695
    [No Abstract]   [Full Text] [Related]  

  • 19. Estrogen carcinogenesis in breast cancer.
    Germain D
    Endocrinol Metab Clin North Am; 2011 Sep; 40(3):473-84, vii. PubMed ID: 21889715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2011 Feb; 103(4):284-5. PubMed ID: 21278357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.